Evidence map›Paper›PMID 36589330›Full record

ArticleRomanian journal of ophthalmology

Off-label uses of Aflibercept, Ranibizumab and Dexamethasone implant for diabetic retinopathy in Turkey.

Mevlut Yilmaz, Mehmet Citirik, Hanife Rahmanlar, Ali Alkan, Hakki Gursoz

Open access · bronzeAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Romanian journal of ophthalmology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 76% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Mevlut YilmazDepartment of Ophthalmology, University of Health Sciences, Ankara Ulucanlar Eye Training and Research Hospital, Ankara, Turkey.
Mehmet CitirikDepartment of Ophthalmology, University of Health Sciences, Ankara Ulucanlar Eye Training and Research Hospital, Ankara, Turkey.
Hanife RahmanlarTurkish Medicines and Medical Devices Agency, Turkish Ministry of Health, Ankara, Turkey.
Ali AlkanTurkish Medicines and Medical Devices Agency, Turkish Ministry of Health, Ankara, Turkey.
Hakki GursozTurkish Medicines and Medical Devices Agency, Turkish Ministry of Health, Ankara, Turkey.
Ministry of Health · TRSağlık Bilimleri Üniversitesi · TRUlucanlar Göz Eğitim ve Araştırma Hastanesi · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Diabetes MellitusDiabetic RetinopathyMacular EdemaAgedAngiogenesis InhibitorsBevacizumabDexamethasoneEndothelial Growth FactorsFemaleHumansIntravitreal InjectionsMaleMiddle AgedOff-Label UseRanibizumabReceptors, Vascular Endothelial Growth FactorafliberceptAngiogenesis InhibitorsBevacizumabDexamethasoneEndothelial Growth FactorsRanibizumabReceptors, Vascular Endothelial Growth FactorRecombinant Fusion Proteinsafliberceptdexamethasone implantdiabetic macular edemadiabetic retinopathyoff-label drugranibizumab

Identifiers

PMID36589330
PMCPMC9773121
OpenAlexW4311962686

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.